Status:
COMPLETED
A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections
Lead Sponsor:
Pfizer
Conditions:
Systemic Fungal Infections
Eligibility:
All Genders
18-75 years
Brief Summary
To collect and summarize information on the diagnosis, management, and clinical and mycological outcomes of patients with systemic fungal infections in order to better understand the effectiveness of ...
Eligibility Criteria
Inclusion
- To be eligible for enrollment in the study database, patients must have received (in the Intensive Care Unit \[ICU\] at study entry) at least 1 day therapy with systemic antifungal agent for treatment of a proven or suspected fungal infection.
Exclusion
- None.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00721578
Start Date
April 1 2009
End Date
December 1 2009
Last Update
January 10 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Pune, Maharashtra, India, 411 001
2
Pfizer Investigational Site
Pune, Maharashtra, India, 411004
3
Pfizer Investigational Site
New Delhi, New Delhi, India, 110 076